ANI Pharmaceuticals vs Braeburn
ANI Pharmaceuticals vs Braeburn, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ANI Pharmaceuticals is on 49/100 and Braeburn on 44/100.
Where each one leads
ANI Pharmaceuticals
- our overall score: 49/100 against 44/100
- domain rating: 56/100 against 47/100
- headcount: 707 against 276
- funding raised: $671M against $133M
- LinkedIn following: 31,660 against 11,143
Braeburn
- agent readiness: 39/100 against 31/100
At a glance
| Measure | ANI Pharmaceuticals | Braeburn |
|---|---|---|
| What it is | Diversified biopharmaceutical company focused on rare diseases, generics, and established brands. | Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain. |
| Category | Biotech, Pharmaceuticals, Rare Disease, Generics | Biotech, HealthTech, Drug Discovery, Biotechnology |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | hardware | services | marketplace | platform | Software | hardware | services | marketplace | platform |
| Founded | 1996 | 2012 |
| Headquarters | Baudette, United States | Plymouth Meeting, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | ANI Pharmaceuticals | Braeburn |
|---|---|---|
| Employees | 707 | 276 |
| Headcount growthLast 12 months | +95.8% | Not published |
| Total funding | $671M | $133M |
| Latest round | Acquisition | Conventional Debt |
| LinkedIn followers | 31,660 | 11,143 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | ANI Pharmaceuticals | Braeburn |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 49/100 | 44/100 |
| Traction | 60/100 | 60/100 |
| Team | 10/100 | 30/100 |
| Search visibility | 23/100 | 33/100 |
| Quality | 58/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (31/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 56/100 | 47/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | ANI Pharmaceuticals | Braeburn |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Jquery, Bootstrap | Jquery, Bootstrap |
| Analytics | Google Analytics 4 | Google Tag Manager |
ANI Pharmaceuticals vs Braeburn: common questions
Which is better, ANI Pharmaceuticals or Braeburn?
On our 0-100 score ANI Pharmaceuticals rates higher (49/100 against 44/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do ANI Pharmaceuticals and Braeburn compare on the numbers?
ANI Pharmaceuticals leads on our overall score (49/100 against 44/100), domain rating (56/100 against 47/100), headcount (707 against 276), funding raised ($671M against $133M), LinkedIn following (31,660 against 11,143). Braeburn leads on agent readiness (39/100 against 31/100).
Read the full ANI Pharmaceuticals review and pricing or the Braeburn review and pricing. You can also browse other ANI Pharmaceuticals alternatives we track.